Universität zu Köln

2016

Wendtner, Clemens-Martin, Byrd, John C., Eichhorst, Barbara, Foa, Robin, Hallek, Michael, Hillmen, Peter, Jager, Ulrich, Jurczak, Wojciech, Kelemen, Peter, Laribi, Kamel, Munir, Talha, Staber, Philipp B., Stilgenbauer, Stephan and Woyach, Jennifer Ann (2016). A phase II study of MOR208 plus idelalisib in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) previously treated with a Bruton's tyrosine kinase inhibitor (MIRACLE). J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755